Table 5.

Distribution of study sample by type of TMDs clinical examination symptoms.

	NT		TP		TS		TD		PS
	n	%	n	%	n	%	n	%	n	%
Male (1766)	1092	61.8% (59.6%, 64.1%)	50	2.8% (2.1%, 3.6%)	516	29.2% (27.1%, 31.3%)	27	1.5% (1.0%, 2.1%)	81	4.6% (3.6%, 5/6%)
Female (1124)	686	61.0% (58.2%, 63.9%)	50	4.4% (3.2%,5.7%)	285	25.4% (22.8%, 27.9%)	49	4.4% (3.2%, 5.6%)	54	4.8% (3.6%, 6.1%)
Total (2890)	1778	61.5% (59.8%, 63.3%)	100	3.5% (2.8%, 4.1%)	801	27.7% (26.1%, 29.4%)	76	2.6% (2.0%, 3.2%)	135	4.7% (3.9%, 5.4%)
P†		.665		.024⁎		.108		<.001⁎⁎		.787

Bold values represent statistically significant results (P <0.05).

^⁎Statistical significance at P < .05

^⁎⁎Significant at P < .001.

^†Comparing the differences in Male and Female. Results of chi-square test (P < .05).